Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2011-5-25
pubmed:abstractText
A prospective, phase III randomized study was undertaken to compare the outcomes of 2 different radiotherapy and chemotherapy sequences in conservatively treated patients with breast cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1537-453X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
34
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
238-44
pubmed:meshHeading
pubmed-meshheading:20805741-Adult, pubmed-meshheading:20805741-Aged, pubmed-meshheading:20805741-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:20805741-Breast Neoplasms, pubmed-meshheading:20805741-Chemotherapy, Adjuvant, pubmed-meshheading:20805741-Cyclophosphamide, pubmed-meshheading:20805741-Disease-Free Survival, pubmed-meshheading:20805741-Drug Administration Schedule, pubmed-meshheading:20805741-Female, pubmed-meshheading:20805741-Fluorouracil, pubmed-meshheading:20805741-Follow-Up Studies, pubmed-meshheading:20805741-Humans, pubmed-meshheading:20805741-Methotrexate, pubmed-meshheading:20805741-Middle Aged, pubmed-meshheading:20805741-Predictive Value of Tests, pubmed-meshheading:20805741-Prognosis, pubmed-meshheading:20805741-Prospective Studies, pubmed-meshheading:20805741-Radiotherapy, Adjuvant, pubmed-meshheading:20805741-Recurrence, pubmed-meshheading:20805741-Risk Assessment, pubmed-meshheading:20805741-Risk Factors, pubmed-meshheading:20805741-Survival Analysis, pubmed-meshheading:20805741-Time Factors, pubmed-meshheading:20805741-Treatment Outcome
pubmed:year
2011
pubmed:articleTitle
Long-term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer.
pubmed:affiliation
Department of Radiotherapy, Regina Elena National Cancer Institute, Rome, Italy.
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Clinical Trial, Phase III